BlackBoxRX
 
We highly recommend enabling Javascript while using the BlackBoxRX site.

Brodalumab

Suicidal Ideation and Behavior

  • Suicidal ideation and behavior, including completed suicides, have occurred in patients treated with SILIQ. 
  • Prior to prescribing, weigh potential risks and benefits in patients with a history of depression and/or suicidal ideation or behavior. Patients with new or worsening suicidal thoughts and behavior should be referred to a mental health professional, as appropriate. 
  • Advise patients and caregivers to seek medical attention for manifestations of suicidal ideation or behavior, new onset or worsening depression, anxiety, or other mood changes. 
  • SILIQ is available only through a restricted program called the SILIQ REMS Program. 

Approved Risk Evaluation and Mitigation Strategies (REMS)

SILIQ (Brodalumab) Injection

Patient Counseling Information

Medication Guides

Patient Medication Guide

Package Inserts

Brodalumab

Updated January 2018